Morita Y - Search Results

1

Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.

Nishimura H, Ito Y, Mizuno M, Tanaka A, Morita Y, Maruyama S, Yuzawa Y, Matsuo S. Nishimura H, et al. Among authors: morita y. Am J Physiol Renal Physiol. 2008 May;294(5):F1084-93. doi: 10.1152/ajprenal.00565.2007. Epub 2008 Mar 19. Am J Physiol Renal Physiol. 2008. PMID: 18353870 Free article.

2

Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice.

Kurata K, Maruyama S, Kato S, Sato W, Yamamoto J, Ozaki T, Nitta A, Nabeshima T, Morita Y, Mizuno M, Ito Y, Yuzawa Y, Matsuo S. Kurata K, et al. Among authors: morita y. Am J Physiol Renal Physiol. 2009 Dec;297(6):F1510-7. doi: 10.1152/ajprenal.90330.2008. Am J Physiol Renal Physiol. 2009. PMID: 19934446 Free article.

3

Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria.

Shimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S, Sato W, Morita Y, Maruyama H, Egashira K, Matsuo S. Shimizu H, et al. Among authors: morita y. J Am Soc Nephrol. 2003 Jun;14(6):1496-505. doi: 10.1097/01.asn.0000069223.98703.8e. J Am Soc Nephrol. 2003. PMID: 12761250

4

The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids.

Liu MC, Maruyama S, Mizuno M, Morita Y, Hanaki S, Yuzawa Y, Matsuo S. Liu MC, et al. Among authors: morita y. Clin Exp Nephrol. 2003 Sep;7(3):186-94. doi: 10.1007/s10157-003-0229-z. Clin Exp Nephrol. 2003. PMID: 14586714

5

Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.

Kato S, Yuzawa Y, Tsuboi N, Maruyama S, Morita Y, Matsuguchi T, Matsuo S. Kato S, et al. Among authors: morita y. J Am Soc Nephrol. 2004 May;15(5):1289-99. J Am Soc Nephrol. 2004. PMID: 15100369

6

Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70.

Suzuki S, Maruyama S, Sato W, Morita Y, Sato F, Miki Y, Kato S, Katsuno M, Sobue G, Yuzawa Y, Matsuo S. Suzuki S, et al. Among authors: morita y. Kidney Int. 2005 Jun;67(6):2210-20. doi: 10.1111/j.1523-1755.2005.00326.x. Kidney Int. 2005. PMID: 15882264 Free article.

7

Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure.

Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y, Ito Y, Gotoh M, Yuzawa Y, Matsuo S. Ozaki T, et al. Among authors: morita y. Nephrol Dial Transplant. 2008 Jan;23(1):110-9. doi: 10.1093/ndt/gfm563. Epub 2007 Sep 5. Nephrol Dial Transplant. 2008. PMID: 17804460

8

High mobility group box chromosomal protein 1 in patients with renal diseases.

Sato F, Maruyama S, Hayashi H, Sakamoto I, Yamada S, Uchimura T, Morita Y, Ito Y, Yuzawa Y, Maruyama I, Matsuo S. Sato F, et al. Among authors: morita y. Nephron Clin Pract. 2008;108(3):c194-201. doi: 10.1159/000118942. Epub 2008 Mar 3. Nephron Clin Pract. 2008. PMID: 18311084

9

Complement activation products in the urine from proteinuric patients.

Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S. Morita Y, et al. J Am Soc Nephrol. 2000 Apr;11(4):700-707. doi: 10.1681/ASN.V114700. J Am Soc Nephrol. 2000. PMID: 10752529

10

Effects of human soluble thrombomodulin on experimental glomerulonephritis.

Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S. Ikeguchi H, et al. Among authors: morita y. Kidney Int. 2002 Feb;61(2):490-501. doi: 10.1046/j.1523-1755.2002.00160.x. Kidney Int. 2002. PMID: 11849389 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,169 results

Search Page

Filters